U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1927811927813-D Laser Imaging to Analyze Neck MovementActive, not recruitingNo Results AvailableNeck Pain|Manipulation, SpinalDevice: 3-D Laser Imaging Devicehttps://ClinicalTrials.gov/show/NCT00022828
192782192782Management of Compartment Syndrome With UltrafiltrationCompletedNo Results AvailableCompartment SyndromeDevice: Tissue ultrafiltrationhttps://ClinicalTrials.gov/show/NCT00022815
192783192783Image Guided System for Orthopaedic SurgeryTerminatedNo Results AvailableOrthopaedic Trauma|Hip FractureDevice: Image-guided surgical systemhttps://ClinicalTrials.gov/show/NCT00022802
192784192784Prevalence of Sleep-Disordered Breathing in ChildrenCompletedNo Results AvailableLung Diseases|Sleep Apnea Syndromeshttps://ClinicalTrials.gov/show/NCT00022789
192785192785Surgical Versus Nonsurgical Treatment for Spinal StenosisCompletedNo Results AvailableSpinal StenosisProcedure: Surgical decompression|Procedure: Physical therapyhttps://ClinicalTrials.gov/show/NCT00022776
192786192786T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and AdolescentsCompletedNo Results AvailableHIV InfectionsDrug: Enfuvirtidehttps://ClinicalTrials.gov/show/NCT00022763
192787192787Randomized Trial of Health Events Costs in Diabetic BlacksCompletedNo Results AvailableDiabetes Mellitus, Type 2Behavioral: Nurse Case Manager and Community Health Worker Teamhttps://ClinicalTrials.gov/show/NCT00022750
192788192788Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic LeukemiaCompletedNo Results AvailableChildhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic LeukemiaBiological: filgrastim|Drug: asparaginase|Drug: cyclophosphamide|Drug: cyclosporine|Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: dexamethasone|Drug: etoposide|Drug: ifosfamide|Drug: imatinib mesylate|Drug: leucovorin calcium|Drug: mercaptopurine tablet|Drug: methotrexate|Drug: pegaspargase|Drug: vincristine sulfate|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Procedure: umbilical cord blood transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00022737
192789192789CCI-779 in Treating Patients With Malignant GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: temsirolimushttps://ClinicalTrials.gov/show/NCT00022724
192790192790Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: temozolomidehttps://ClinicalTrials.gov/show/NCT00022711
192791192791Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: capecitabine|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00022698
192792192792Epratuzumab in Treating Patients With Non-Hodgkin's LymphomaActive, not recruitingNo Results AvailableLymphomaBiological: epratuzumabhttps://ClinicalTrials.gov/show/NCT00022685
192793192793A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast CancerCompletedHas ResultsBreast CancerDrug: trastuzumab (Herceptin®)|Drug: anastrazole (Arimidex®)https://ClinicalTrials.gov/show/NCT00022672
192794192794Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedHas ResultsPrimary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial CancerBiological: bevacizumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00022659
192795192795Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: gemcitabine hydrochloride|Drug: pemetrexed disodiumhttps://ClinicalTrials.gov/show/NCT00022646
192796192796S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary TractTerminatedNo Results AvailableBladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral CancerDrug: gemcitabine hydrochloride|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00022633
192797192797Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00022620
192798192798Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmBiological: bevacizumab|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00022607
192799192799Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: liposomal lurtotecanhttps://ClinicalTrials.gov/show/NCT00022594
192800192800Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableRecurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Small Lymphocytic LymphomaDrug: thalidomide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00022581
192801192801Vaccine Therapy in Treating Patients With Metastatic MelanomaActive, not recruitingNo Results AvailableMelanoma (Skin)Biological: recombinant vaccinia-TRICOM vaccinehttps://ClinicalTrials.gov/show/NCT00022568
192802192802Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related LymphomaCompletedNo Results AvailableAIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Small Noncleaved Cell LymphomaDrug: bryostatin 1|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00022555
192803192803BMS-247550 in Treating Patients With Advanced Soft Tissue SarcomaTerminatedNo Results AvailableRecurrent Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue SarcomaDrug: ixabepilonehttps://ClinicalTrials.gov/show/NCT00022542
192804192804BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: BMS-214662|Biological: trastuzumab|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00022529
192805192805Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: CAF regimen|Drug: CMF regimen|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: epirubicin hydrochloride|Drug: fluorouracil|Drug: methotrexate|Procedure: adjuvant therapy|Drug: Paclitaxel|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00022516
192806192806Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous LeukemiaTerminatedHas ResultsLeukemiaDrug: cytarabine|Drug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00022490
192807192807BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: BMS-247550https://ClinicalTrials.gov/show/NCT00022477
192808192808CCI-779 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Drug: temsirolimushttps://ClinicalTrials.gov/show/NCT00022464
192809192809Tipifarnib in Treating Young Patients With Refractory LeukemiaCompletedNo Results AvailableLeukemiaDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00022451
192810192810Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous TreatmentCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: incomplete Freund's adjuvant|Biological: recombinant tyrosinase-related protein-2https://ClinicalTrials.gov/show/NCT00022438

* Görseller ve İçerik tekif hakkına sahip olabilir